Published in Cell Res on August 23, 2011
Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer. Oncogene (2017) 1.39
CD133: a stem cell biomarker and beyond. Exp Hematol Oncol (2013) 1.24
Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo. PLoS One (2012) 1.19
Coaction of spheroid-derived stem-like cells and endothelial progenitor cells promotes development of colon cancer. PLoS One (2012) 0.95
Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition. Oncotarget (2015) 0.93
MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. J Exp Clin Cancer Res (2015) 0.90
The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review). Int J Oncol (2014) 0.88
Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol (2016) 0.88
Eupolyphaga sinensis walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling. Sci Rep (2014) 0.87
Research progress and prospects of markers for liver cancer stem cells. World J Gastroenterol (2015) 0.86
Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. PLoS One (2013) 0.78
The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cells Int (2016) 0.75
Targeted multimodal nano-reporters for pre-procedural MRI and intra-operative image-guidance. Biomaterials (2016) 0.75
Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome. Onco Targets Ther (2016) 0.75
The 2013 special issue on stem cell biology. Cell Res (2013) 0.75
Properties and feasibility of using cancer stem cells in clinical cancer treatment. Cancer Biol Med (2016) 0.75
The Interaction between Cancer Stem Cell Marker CD133 and Src Protein Promotes Focal Adhesion Kinase (FAK) Phosphorylation and Cell Migration. J Biol Chem (2016) 0.75
CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis. Biomed Res Int (2017) 0.75
c-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells. Am J Cancer Res (2015) 0.75
Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma. Oncogenesis (2017) 0.75
Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Sci Rep (2017) 0.75
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Cancers (Basel) (2017) 0.75
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective. Front Oncol (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 17.49
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med (2008) 9.20
Cancer stem cells: models and concepts. Annu Rev Med (2007) 8.06
Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 6.48
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res (2006) 6.35
Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer (1999) 6.11
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene (2006) 5.86
Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology (2007) 5.75
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology (2008) 5.53
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood (1997) 5.04
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer (2007) 3.65
Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology (2009) 3.42
Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum (2002) 2.97
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res (2008) 2.82
Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc (2007) 2.54
Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer (2010) 2.54
A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol (2003) 2.50
The phenotypes of pluripotent human hepatic progenitors. Stem Cells (2006) 2.41
Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res (2006) 2.32
Isolation and characterization of a stem cell population from adult human liver. Stem Cells (2006) 2.25
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery (2000) 2.14
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract (2008) 1.62
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer (2006) 1.48
miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun (2010) 1.30
Expression of chemokines and chemokine receptors in human colon cancer. Methods Enzymol (2009) 1.14
Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J Cancer Res Clin Oncol (2000) 1.13
Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol (2007) 1.08
Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter. Cancer Lett (2008) 1.05
CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol (1996) 1.01
Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer. Gut (2009) 0.95
Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism. Cancer Res (2004) 0.91
Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study. Liver (1997) 0.90
High-efficiency gene transfer into cultured embryonic motoneurons using recombinant lentiviruses. Histochem Cell Biol (2006) 0.89
Expression of CD44 in human hepatocellular carcinoma cell lines. Hepatology (1995) 0.81
Cancer survival in Shanghai, People's Republic of China. IARC Sci Publ (1998) 0.78
Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis. World J Surg (1997) 0.77
Resection of hepatocellular carcinoma: oligocentric origin of recurrent and multinodular tumours. J Gastroenterol Hepatol (1991) 0.76
Shock-synthesized hexagonal diamonds in Younger Dryas boundary sediments. Proc Natl Acad Sci U S A (2009) 3.33
TRPC channels promote cerebellar granule neuron survival. Nat Neurosci (2007) 2.47
Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol (2013) 2.16
Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology (2011) 2.13
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol (2008) 1.88
GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet (2012) 1.86
Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One (2010) 1.82
Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'. Nat Chem Biol (2008) 1.74
Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity. Neuropharmacology (2007) 1.41
Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy (2009) 1.39
Retracted Comparison of the sagittal profiles among thoracic idiopathic scoliosis patients with different Cobb angles and growth potentials. J Orthop Surg Res (2014) 1.39
Modular chemical mechanism predicts spatiotemporal dynamics of initiation in the complex network of hemostasis. Proc Natl Acad Sci U S A (2006) 1.36
Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial. Ann Surg (2015) 1.33
Theoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfluidic digital PCR. Anal Chem (2011) 1.32
Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst (2010) 1.29
Critical role of TRPC6 channels in the formation of excitatory synapses. Nat Neurosci (2008) 1.22
p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology (2010) 1.21
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer Res (2008) 1.21
Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome. Hepatology (2010) 1.21
Requirement of dendritic Akt degradation by the ubiquitin-proteasome system for neuronal polarity. J Cell Biol (2006) 1.20
RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS One (2011) 1.18
Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. J Integr Med (2013) 1.17
Progress in research of liver surgery in China. World J Gastroenterol (2000) 1.17
Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Ann Surg (2013) 1.16
Characterization of the threshold response of initiation of blood clotting to stimulus patch size. Biophys J (2007) 1.15
Canonical transient receptor potential 3 channels regulate mitochondrial calcium uptake. Proc Natl Acad Sci U S A (2013) 1.14
Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B. Dig Dis Sci (2014) 1.13
Corosolic acid induces apoptosis through mitochondrial pathway and caspase activation in human cervix adenocarcinoma HeLa cells. Cancer Lett (2009) 1.13
Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Lett (2009) 1.12
CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma. Int J Cancer (2008) 1.11
Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Ann Surg Oncol (2010) 1.10
Appeal from Chinese doctors to end violence. Lancet (2013) 1.09
TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway. J Cell Sci (2008) 1.07
Long-term but not short-term blockade of dopamine release in Drosophila impairs orientation during flight in a visual attention paradigm. Eur J Neurosci (2004) 1.07
MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Gastroenterology (2013) 1.05
Influence of interchannel spacing on the dynamical properties of multichannel quartz crystal microbalance. IEEE Trans Ultrason Ferroelectr Freq Control (2004) 1.05
Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. Int J Cancer (2009) 1.04
Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. J Cancer Res Clin Oncol (2010) 1.01
Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study. J Gastrointest Surg (2014) 1.01
Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol Cell Biol (2009) 1.00
Mechanistic evaluation of the pros and cons of digital RT-LAMP for HIV-1 viral load quantification on a microfluidic device and improved efficiency via a two-step digital protocol. Anal Chem (2013) 0.99
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology (2012) 0.98
Krüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma. PLoS One (2012) 0.97
Spontaneous complete necrosis of hepatocellular carcinoma: a case report. Hepatobiliary Pancreat Dis Int (2003) 0.96
Enucleation of liver hemangiomas: is there a difference in surgical outcomes for centrally or peripherally located lesions? Am J Surg (2009) 0.96
Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors. Dig Dis Sci (2014) 0.96
Hepatic arterial iodine-131-labeled metuximab injection combined with chemoembolization for unresectable hepatocellular carcinoma: interim safety and survival data from 110 patients. Cancer Biother Radiopharm (2010) 0.95
Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats. J Clin Invest (2010) 0.95
Hemorrhagic hepatic cysts mimicking biliary cystadenoma. World J Gastroenterol (2009) 0.95
Functional roles of TRPC channels in the developing brain. Pflugers Arch (2008) 0.93
Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma. J Cell Biochem (2011) 0.93
Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent. PLoS One (2012) 0.93
miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumour Biol (2014) 0.92
Neuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis. PLoS One (2012) 0.91
Effects of p-glycoprotein on steroid-induced osteonecrosis of the femoral head. Calcif Tissue Int (2010) 0.90
[Effects of electroacupuncture on the expression of GDNF and Ret in Parkinson's disease model rats]. Zhongguo Zhen Jiu (2010) 0.89
Trigeminal neuralgia: what are the important factors for good operative outcomes with microvascular decompression. Surg Neurol (2004) 0.89
Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. J Surg Oncol (2008) 0.88
Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior. Ann Surg Oncol (2011) 0.88
The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2012) 0.87
Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma. Biochem Biophys Res Commun (2007) 0.87
The Kv2.1 channels mediate neuronal apoptosis induced by excitotoxicity. J Neurochem (2008) 0.87
MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1. Cell Physiol Biochem (2014) 0.87
TRPC5 channel is the mediator of neurotrophin-3 in regulating dendritic growth via CaMKIIα in rat hippocampal neurons. J Neurosci (2012) 0.86
TRPC6 inhibited NMDA receptor activities and protected neurons from ischemic excitotoxicity. J Neurochem (2012) 0.86
Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and β-amyloid deposition in Alzheimer's disease models. PLoS One (2012) 0.86
Elevated SHOX2 expression is associated with tumor recurrence of hepatocellular carcinoma. Ann Surg Oncol (2013) 0.86
Targeting TRPC6 channels in oesophageal carcinoma growth. Expert Opin Ther Targets (2010) 0.86
Selective main portal vein clamping to minimize the risk of recurrence after curative liver resection for hepatocellular carcinoma. Hepatogastroenterology (2012) 0.85
Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study. Hepatogastroenterology (2012) 0.85
Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load. Ann Surg Oncol (2012) 0.85
Characterization of ZNF23, a KRAB-containing protein that is downregulated in human cancers and inhibits cell cycle progression. Exp Cell Res (2006) 0.85
Studies on the operative outcomes and mechanisms of microvascular decompression in treating typical and atypical trigeminal neuralgia. Clin J Pain (2005) 0.85
Antioxidant peptidomics reveals novel skin antioxidant system. Mol Cell Proteomics (2008) 0.85
Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study. Eur J Nucl Med Mol Imaging (2012) 0.85
VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis. Tumour Biol (2014) 0.85
Cruciate ligament reconstruction using LARS artificial ligament under arthroscopy: 81 cases report. Chin Med J (Engl) (2010) 0.84
Response to shape emerges in a complex biochemical network and its simple chemical analogue. Angew Chem Int Ed Engl (2007) 0.84
Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. Ann Surg Oncol (2014) 0.84
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection. Ann Surg Oncol (2011) 0.83
The alpha subunit of the G protein G13 regulates activity of one or more Gli transcription factors independently of smoothened. J Biol Chem (2011) 0.83
Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation. J Cancer Res Clin Oncol (2008) 0.83
Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients. J Proteome Res (2010) 0.83
Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study. Hepatobiliary Pancreat Dis Int (2002) 0.83
Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies. Oncologist (2012) 0.83
Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas. Ann Surg (2016) 0.82
Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial. J Mater Sci Mater Med (2010) 0.82
A microfluidic device for dry sample preservation in remote settings. Lab Chip (2013) 0.82
Low K+ promotes NF-kappaB/DNA binding in neuronal apoptosis induced by K+ loss. Mol Cell Biol (2006) 0.82
The study of physics and thermal characteristics for in-hospital neutron irradiator (IHNI). Appl Radiat Isot (2009) 0.81
A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatogastroenterology (2012) 0.81
Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial. PLoS One (2013) 0.81
Preoperative portal vein embolization for hilar cholangiocarcinoma--a comparative study. Hepatogastroenterology (2011) 0.81
Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis. J Gastrointest Surg (2015) 0.81
Neuronal transmission stimulates the phosphorylation of Kv1.4 channel at Ser229 through protein kinase A1. J Neurochem (2005) 0.80